Literature DB >> 7320696

Polypeptide composition of Chlamydia trachomatis.

S H Salari, M E Ward.   

Abstract

Strains of Chlamydia trachomatis representative of 14 serotypes were grown in HeLa 229 cells. HeLa cell susceptibility to chlamydial infection was increased by treating the host cells with DEAE-dextran. Optimal conditions of DEAE-dextran treatment were determined for each serotype of C. trachomatis to maximize chlamydial yields. Chlamydial polypeptides were selectively radiolabelled with 3H-labelled amino acids in the presence of emetine, an inhibitor of HeLa cell protein synthesis. The radiolabelled chlamydiae were purified from host cell components by density gradient centrifugation and their polypeptide composition was determined by sodium dodecyl sulphate-polyacrylamide gel electrophoresis. The distribution of the major chlamydial polypeptide of 38 000 to 42 000 daltons amongst the different serotypes correlated closely with the predominant human infections caused by each serotype. Lymphogranuloma venereum agents possessed a unique polypeptide of 118 000 daltons not found amongst trachoma inclusion conjunctivitis strains of chlamydiae. Chlamydial surface polypeptides were selectively radiolabelled with 125I by lactoperoxidase-catalysed oxidation. The major chlamydial polypeptide and polypeptides of 155 000 and 29 000 daltons were thus identified as surface polypeptides of the chlamydial elementary body. It is suggested that the 155 000 dalton polypeptide is a species-specific antigen, the major polypeptide is the principal outer membrane protein, and the 29 000 dalton polypeptide is the type-specific antigen.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7320696     DOI: 10.1099/00221287-123-2-197

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  36 in total

1.  Identification of surface-exposed components of MOMP of Chlamydia trachomatis serovar F.

Authors:  Yan Wang; Eric A Berg; Xiaogeng Feng; Li Shen; Temple Smith; Catherine E Costello; You-xun Zhang
Journal:  Protein Sci       Date:  2005-12-01       Impact factor: 6.725

2.  Identification of two novel genes encoding 97- to 99-kilodalton outer membrane proteins of Chlamydia pneumoniae.

Authors:  K Knudsen; A S Madsen; P Mygind; G Christiansen; S Birkelund
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Detection of the surface-exposed 18-kilodalton binding protein in Chlamydia trachomatis by immunogold staining.

Authors:  G J Gray; R Kaul; R Sherburne; W M Wenman
Journal:  J Bacteriol       Date:  1990-06       Impact factor: 3.490

4.  Chlamydial and gonococcal antibodies in sera of infertile women with tubal obstruction.

Authors:  J N Robertson; M E Ward; D Conway; E O Caul
Journal:  J Clin Pathol       Date:  1987-04       Impact factor: 3.411

Review 5.  Diagnosis and assessment of trachoma.

Authors:  Anthony W Solomon; Rosanna W Peeling; Allen Foster; David C W Mabey
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 6.  Chlamydia trachomatis: serological diagnosis.

Authors:  J D Treharne
Journal:  Infection       Date:  1982       Impact factor: 3.553

7.  Molecular cloning of the major outer membrane protein of Chlamydia trachomatis.

Authors:  I Allan; T M Cunningham; M A Lovett
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

8.  Tear and serum antibody response to Chlamydia trachomatis antigens during acute chlamydial conjunctivitis in monkeys as determined by immunoblotting.

Authors:  H D Caldwell; S Stewart; S Johnson; H Taylor
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

9.  Analysis of cytokine profiles in synovial T cell clones from chlamydial reactive arthritis patients: predominance of the Th1 subset.

Authors:  A K Simon; E Seipelt; P Wu; B Wenzel; J Braun; J Sieper
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

10.  Antigenic analysis of the major outer membrane protein of Chlamydia spp.

Authors:  H D Caldwell; J Schachter
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.